SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 1998

Primary Completion Date

May 31, 2007

Study Completion Date

June 30, 2007

Conditions
Myelodysplastic SyndromeAcute Myeloblastic Leukemia
Interventions
DRUG

Fludarabine

DRUG

Cytarabine

DRUG

G-CSF

DRUG

Idarubicin

PROCEDURE

Peripheral blood stem cell transplantation

PROCEDURE

Bone marrow transplantation

Trial Locations (15)

Unknown

Hospital de la Ribera, Alzira

Hospital Germans Trias i Pujol, Badalona

Hospital del Mar, Barcelona

Hospital Vall d'Hebron, Barcelona

Hospital Puerta del Mar, Cadiz

Hospital del SAS, Jerez de la Frontera

Hospital de Leon, León

Hospital Clínico San Carlos, Madrid

Hospital Universitario La Paz, Madrid

Hospital Morales Messeguer, Murcia

Hospital Central de Asturias, Oviedo

Hospital Clínico de Salamanca, Salamanca

Hospital Arnau de Vilanova, Valencia

Hospital Dr. Pesset, Valencia

Hospital Universitario La Fe, Valencia

All Listed Sponsors
lead

PETHEMA Foundation

OTHER

NCT00487448 - SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic Leukemia | Biotech Hunter | Biotech Hunter